Stegmann C, Hochdorfer D, Lieber D, Subramanian N, Stohr D, Laib Sampaio K
PLoS Pathog. 2017; 13(4):e1006273.
PMID: 28403220
PMC: 5389858.
DOI: 10.1371/journal.ppat.1006273.
Maidji E, Genbacev O, Chang H, Pereira L
J Virol. 2007; 81(9):4701-12.
PMID: 17314173
PMC: 1900158.
DOI: 10.1128/JVI.02748-06.
Wang D, Shenk T
Proc Natl Acad Sci U S A. 2005; 102(50):18153-8.
PMID: 16319222
PMC: 1312424.
DOI: 10.1073/pnas.0509201102.
Kinzler E, Compton T
J Virol. 2005; 79(12):7827-37.
PMID: 15919936
PMC: 1143629.
DOI: 10.1128/JVI.79.12.7827-7837.2005.
Rasmussen L, Geissler A, Cowan C, Chase A, Winters M
J Virol. 2002; 76(21):10841-8.
PMID: 12368327
PMC: 136653.
DOI: 10.1128/jvi.76.21.10841-10848.2002.
Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells.
Theiler R, Compton T
J Virol. 2002; 76(6):2890-8.
PMID: 11861856
PMC: 135985.
DOI: 10.1128/jvi.76.6.2890-2898.2002.
Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge.
Ye M, Morello C, Spector D
J Virol. 2002; 76(5):2100-12.
PMID: 11836387
PMC: 153826.
DOI: 10.1128/jvi.76.5.2100-2112.2002.
In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection.
Wang J, Jiang H, Liu F
RNA. 2000; 6(4):571-83.
PMID: 10786848
PMC: 1369938.
DOI: 10.1017/s1355838200992215.
Intracellular formation and processing of the heterotrimeric gH-gL-gO (gCIII) glycoprotein envelope complex of human cytomegalovirus.
Huber M, Compton T
J Virol. 1999; 73(5):3886-92.
PMID: 10196283
PMC: 104166.
DOI: 10.1128/JVI.73.5.3886-3892.1999.
Strain-specific neutralization of human cytomegalovirus isolates by human sera.
Klein M, Schoppel K, Amvrossiadis N, Mach M
J Virol. 1999; 73(2):878-86.
PMID: 9882288
PMC: 103907.
DOI: 10.1128/JVI.73.2.878-886.1999.
The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex.
Huber M, Compton T
J Virol. 1998; 72(10):8191-7.
PMID: 9733861
PMC: 110166.
DOI: 10.1128/JVI.72.10.8191-8197.1998.
Identification and characterization of the guinea-pig cytomegalovirus glycoprotein H gene.
Brady R, Schleiss M
Arch Virol. 1996; 141(12):2409-24.
PMID: 9526546
DOI: 10.1007/BF01718640.
Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex.
Huber M, Compton T
J Virol. 1997; 71(7):5391-8.
PMID: 9188610
PMC: 191778.
DOI: 10.1128/JVI.71.7.5391-5398.1997.
The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection.
Yurochko A, Hwang E, Rasmussen L, Keay S, Pereira L, Huang E
J Virol. 1997; 71(7):5051-9.
PMID: 9188570
PMC: 191738.
DOI: 10.1128/JVI.71.7.5051-5059.1997.
Glycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex.
Li L, Nelson J, Britt W
J Virol. 1997; 71(4):3090-7.
PMID: 9060671
PMC: 191440.
DOI: 10.1128/JVI.71.4.3090-3097.1997.
Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.
Ohlin M, Sundqvist V, Mach M, Wahren B, Borrebaeck C
J Virol. 1993; 67(2):703-10.
PMID: 7678304
PMC: 237421.
DOI: 10.1128/JVI.67.2.703-710.1993.
Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites.
Simpson J, Chow J, Baker J, Avdalovic N, Yuan S, Au D
J Virol. 1993; 67(1):489-96.
PMID: 7677958
PMC: 237386.
DOI: 10.1128/JVI.67.1.489-496.1993.
Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding.
Billstrom M, Britt W
J Virol. 1995; 69(11):7015-22.
PMID: 7474121
PMC: 189621.
DOI: 10.1128/JVI.69.11.7015-7022.1995.
Comparison of antiviral activities of cloned and native human interferons against herpes simplex virus types 1 and 2 and human cytomegalovirus.
Rasmussen L, Chen P, Merigan T
Antimicrob Agents Chemother. 1984; 26(4):599-600.
PMID: 6097170
PMC: 179974.
DOI: 10.1128/AAC.26.4.599.
Inhibition of human cytomegalovirus replication by 9-(1,3-dihydroxy-2-propoxymethyl)guanine alone and in combination with human interferons.
Rasmussen L, Chen P, Mullenax J, Merigan T
Antimicrob Agents Chemother. 1984; 26(4):441-5.
PMID: 6097163
PMC: 179941.
DOI: 10.1128/AAC.26.4.441.